SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology NOS2A products
includes other brands or spellings
|
| ih | | Santa Cruz Biotechnology monoclonal mouse anti-serum against the C-terminal domain of iNOS of human origin antibody sc-7271 was used in paraffin sections from human gastric precancerous and cancerous lesions and in immunohistochemistry to study the correlation of expression of p53, VEGF and iNOS and clinical features in gastric carcinogenesis. |
| wb | | Santa Cruz Biotechnology inducible nitric-oxide synthase antibody was used in western blot to study its activation by the NAD (P) H oxidase inhibitor 4- (2-aminoethyl) benzenesulfonyl fluoride. |
BD BIOSCIENCES search BD Biosciences NOS2A products
includes other brands or spellings
|
| ic, ih | | BD Transduction Laboratories mouse monoclonal iNOS antibody was used in immunohistochemistry and immunocytochemistry to study the promotion of squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways by EP2 prostanoid receptor. |
| ic, wb | | Transduction Laboratories murine monoclonal anti-human NOS2 antibody was used in type II human alveolar epithelial cells (AEC II) and human alveolar type II epithelium-like cell line A549 and in immunocytochemistry, western blot to study the expression of NOS2 and NOS3 mRNA in human A549 cells and primary cultured AEC II. |
| ic, wb | | Transduction Laboratories monoclonal and polyclonal anti-iNOS antibodies were used in human bronchial epithelial 16HBE14o cells and were respectively used in western blot, immunocytochemistry and immunocytochemistry to study the interaction of human epithelial iNOS with EBP50 and the effect of which on polarized epithelial cell functions. |
| ic, wb | | BD Transduction Laboratories mouse monoclonal iNOS antibody was used in western blot and immunocytochemistry to study NOS in human mast cell lines. |
| ih | | Transduction Laboratories mouse anti-iNOS monoclonal antibody was used in immunohistochemistry to study the down-regulation of iNOS expression by MDA-7 in melanoma cells. |
| ih | | Transduction Laboratories anti-human iNOS mouse monoclonal antibody was used in immunohistochemistry to study the association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis. |
| wb | | Transduction Laboratories monoclonal anti-iNOS antibody was used in western blot to detect iNOS in L6 myocytes, 3T3-L1 adipocytes and macrophages. |
| wb | | Transduction Laboratories monoclonal antibody against mouse iNOS with cross-reactivity for human iNOS was used in western blot to study endothelial nitric oxide synthase (eNOS) expression in human pregnant myometrium. |
| wb | | BD Biosciences monoclonal anti-iNOS/NOS type II antibody was used in western blot to study cytokine effect on oligodendrocytes. |
MILLIPORE search Millipore NOS2A products
includes other brands or spellings
|
| ih | | Upstate NOS2A antibody was tested in immunohistochemistry by HPA (CAB002014) . |
| ih | | Chemicon International rabbit anti-iNOS polyclonal antibody was used in immunohistochemistry to study the inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma. |
| wb | | Chemicon International human polyclonal anti-iNOS antibody was used in paraffin sections from human primary sporadic colorectal adenocarcinomas and in western blot to study the expression of iNOS and its activity in human colorectal tumors. |
ALEXIS search Alexis NOS2A products
includes other brands or spellings
|
| ih | | Alexis rabbit polyclonal anti-iNOS antibody was used in paraffin sections from human primary sporadic colorectal adenocarcinomas and in immunohistochemistry to study the expression of iNOS and its activity in human colorectal tumors. |
BOSTER BIOTECHNOLOGY
|
| ih | | Boster Biotechnology anti-iNOS antibody was used in paraffin sections from human gastric carcinoma and in immunohistochemistry to study the relationship between the expression of inducible nitric oxide synthase (iNOS), vascular endothelial growth factor (VEGF), the microvascular density (MVD) and the pathological features and clinical staging of gastric cancer. |
BIOMOL
|
| ih | | Biomol rabbit polyclonal anti-iNOS antibody was used in paraffin sections from human primary sporadic colorectal adenocarcinomas and in immunohistochemistry to study the expression of iNOS and its activity in human colorectal tumors. |
CAYMAN
|
| wb | | Cayman mouse monoclonal iNOS antibody was used in western blot to study the promotion of squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways by EP2 prostanoid receptor. |
Articles Reviewed |
| 1. D V Pechkovsky et al. Pattern of NOS2 and NOS3 mRNA expression in human A549 cells and primary cultured AEC II. 2002 |
| 2. Chang Wei Feng et al. Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features. 2002 |
| 3. Paul A Glynne et al. Epithelial inducible nitric-oxide synthase is an apical EBP50-binding protein that directs vectorial nitric oxide output. 2002 |
| 4. Zheng-Jun Song et al. Relationship between the expression of iNOS,VEGF,tumor angiogenesis and gastric cancer. 2002 |
| 5. Masahide Ikeguchi et al. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma. 2002 |
| 6. Suhendan Ekmekcioglu et al. Negative association of melanoma differentiation-associated gene (mda-7) and inducible nitric oxide synthase (iNOS) in human melanoma: MDA-7 regulates iNOS expression in melanoma cells. 2003 |
| 7. Fabio Cianchi et al. Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis. 2003 |
| 8. Kazuyo Kakui et al. Augmented endothelial nitric oxide synthase (eNOS) protein expression in human pregnant myometrium: possible involvement of eNOS promoter activation by estrogen via both estrogen receptor (ER)alpha and ERbeta. 2004 |
| 9. Geneviève Pilon et al. Inhibition of inducible nitric-oxide synthase by activators of AMP-activated protein kinase: a new mechanism of action of insulin-sensitizing drugs. 2004 |
| 10. Mark Gilchrist et al. Expression, localization, and regulation of NOS in human mast cell lines: effects on leukotriene production. 2004 |
| 11. Katsuhiko Nosho et al. Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis. 2005 |
| 12. Nadiya M Druzhyna et al. Cytokines induce nitric oxide-mediated mtDNA damage and apoptosis in oligodendrocytes. Protective role of targeting 8-oxoguanine glycosylase to mitochondria. 2005 |
| 13. Nastiti Wijayanti et al. Heme oxygenase-1 gene activation by the NAD(P)H oxidase inhibitor 4-(2-aminoethyl) benzenesulfonyl fluoride via a protein kinase B, p38-dependent signaling pathway in monocytes. 2005 |
| 14. Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |
| 15. Sandra Donnini et al. EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways. 2007 |